During the past decade, AbbVie Clinical Pharmacology Research Unit (ACPRU) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "AbbVie Clinical Pharmacology Research Unit (ACPRU)" #1 collaborator was "AbbVie" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "AbbVie Clinical Pharmacology Research Unit (ACPRU)" are "Healthy Volunteers" (2 trials) and "Bioavailability" (1 trials). Many other conditions were trialed in "AbbVie Clinical Pharmacology Research Unit (ACPRU)" in a lesser frequency.

Most popular intervention types in "AbbVie Clinical Pharmacology Research Unit (ACPRU)" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "DSM265 25% SDD powder for suspension" (1 trials), "DSM265 25% SDD, 400 mg fasted" (1 trials), "DSM265 50% SDD granules" (1 trials), "DSM265-TPGS 34% SDD, 400 mg fasted" (1 trials) and "DSM265-TPGS 34% SDD, 400 mg fed" (1 trials). Other intervention names were less common.

The vast majority of trials in "AbbVie Clinical Pharmacology Research Unit (ACPRU)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "AbbVie Clinical Pharmacology Research Unit (ACPRU)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in AbbVie Clinical Pharmacology Research Unit (ACPRU), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in AbbVie Clinical Pharmacology Research Unit (ACPRU), 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".